Cargando…
The history of small extracellular vesicles and their implication in cancer drug resistance
Small extracellular vesicles (EVs) in the last 20 years are demonstrated to possess promising properties as potential new drug delivery systems, biomarkers, and therapeutic targets. Moreover, EVs are described to be involved in the most important steps of tumor development and progression including...
Autores principales: | Palazzolo, Stefano, Canzonieri, Vincenzo, Rizzolio, Flavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451101/ https://www.ncbi.nlm.nih.gov/pubmed/36091133 http://dx.doi.org/10.3389/fonc.2022.948843 |
Ejemplares similares
-
Cancer Extracellular Vesicles: Next-Generation Diagnostic and Drug Delivery Nanotools
por: Palazzolo, Stefano, et al.
Publicado: (2020) -
Application of engineered extracellular vesicles to overcome drug resistance in cancer
por: Nonaka, Taichiro
Publicado: (2022) -
Cancer Organoids in Basic Science and Translational Medicine
por: Memeo, Lorenzo, et al.
Publicado: (2021) -
Early Warnings by Liver Organoids on Short- and Long-Chain PFAS Toxicity
por: Palazzolo, Stefano, et al.
Publicado: (2022) -
STARD3: A Prospective Target for Cancer Therapy
por: Asif, Kanwal, et al.
Publicado: (2021)